Welcome to the Next Generation Lipid-Based Nanoparticles Delivery Summit
After 2 decades of research, lipid-based nanoparticles have finally become clinically viable delivery vehicle following advanced technologies. The success of mRNA vaccines is merely touching the tip of the iceberg of their therapeutic potential, and we have reached the inflection point of leveraging second generation lipids NPs to deliver innovative treatment for patients.
The Next Generation Lipid-Based Nanoparticles Summit is premiering this July to supercharge your particle engineering for novel drug delivery with 2nd generation of lipid based NPs.
You will leave with practical takeaways to:
Assess the current state of play of the lipid-based nanoparticle landscape from liposomes to LNPs and evaluate limitations and advantages of these platforms
Navigate complex payloads and overcome unique challenges such as co-delivery of multiple components to the cytosol
Enable organ and cell-targeted delivery to both hepatic and extrahepatic cells by minimizing dose-limiting toxicity to drastically increase efficacy
Explore next-gen administration routes including inhaled LNP formulations and spray drying of nanoparticles for intratracheal delivery
Elevate clinical design for lipid-based nanoparticle candidates to navigate a successful journey to clinic